The Prostate Cancer Foundation agrees with the American Urological Association that PSA screening provides important information for men and their doctors.
PSA检查能为病人和他们的医生提供重要信息，在这一点上前列腺癌基金会和美国泌尿协会意见一致。
In this case, for men 75 and older, the United States Preventive Services Task Force concluded that screening for prostate cancer does more harm than good.
在这个例子上，美国预防服务工作组(United States PreventiveServicesTask Force)的结论：对75岁以上的男人进行前列腺癌筛查弊大于利。
Reeves says that screening for prostate cancer sometimes finds tumors that wouldn't cause any problems if left untreated. Many professional medical organizations agree.
Reeves说，扫描前列腺癌有时发现一些即使不治疗也不会造成任何伤害的肿块，而许多职业的医学组织也认可这个观点。
The USPSTF comments that since its last review in 2002, no good-quality randomized controlled trials of screening for prostate cancer have been completed.
USPSTF评论说自从2002年作过回顾综述以后，尚没有已完成的高质量的前列腺癌方面的随机对照研究。
Men in the screening group in the European Randomized Study of Screening for Prostate Cancer were 20% less likely than those in the control group to die from prostate cancer.
欧洲前列腺癌筛查随机对照研究中，筛查组中死于前列腺癌的患者的比例比对照组低将近20%。
The study's results suggest that because infertility may be an identifiable risk factor for prostate cancer, early screening may be warranted in infertile men.
研究结果表明不育症一个对于前列癌是确定的危险因素，早年在不育症患者的筛查证明了结论。
In 2006, our Cochrane review identified insufficient evidence to either support or refute the use of routine mass, selective, or opportunistic screening for prostate cancer.
2006年，我们的考科蓝文献找不出充分的证据支持或反驳使用常规大规模、选择性或伺机性的方式来进行摄护腺癌筛检。
To determine whether screening for prostate cancer reduces prostate cancer-specific mortality or all-cause mortality and to assess its impact on quality of life and adverse events.
判断摄护腺癌筛检是否能降低摄护腺癌死亡率或总死亡率，并评估它对于生活品质及不良事件的影响。
To determine whether screening for prostate cancer reduces prostate cancer-specific mortality or all-cause mortality and to assess its impact on quality of life and adverse events.
判断摄护腺癌筛检是否能降低摄护腺癌死亡率或总死亡率，并评估它对于生活品质及不良事件的影响。
应用推荐